Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil bans "cottage industry" mercury blood pressure monitors:

This article was originally published in Clinica

Executive Summary

The Brazilian healthcare surveillance agency - Agencia Nacional de Vigilancia Sanitaria (Anvisa) - has banned the use of "cottage industry" mercury-based blood-pressure monitors in all healthcare settings involving invasive procedures. The ban of these devices - described as "low cost mercury-filled J-shaped tubes" - was legislated under Resolution RE16 of July 6 2004. The measure follows the discovery of their use during an inspection of hospitals in the cities of Sao Paulo and Vitoria. "Their use can expose patients and health workers to liquid mercury and its gases, which are carcinogenic," said Anvisa, pointing at the availability of "electronic devices registered by Anvisa that perform the same function without the health risks".

Topics

UsernamePublicRestriction

Register

MT059222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel